TY  - JOUR

T1  - Abstract P6-17-01: Adjuvant treatment with zoledronic acid (ZOL) in stage II/III breast cancer. The AZURE trial (BIG 01/04) 10 year follow-up

JO  - Cancer Research

UR  - http://dx.doi.org/10.1158/1538-7445.sabcs16-p6-17-01

PY  - 2017/02/15

AU  - Coleman R

AU  - Collinson M

AU  - Bell R

AU  - Marshall H

AU  - Dodwell D

AU  - Keane M

AU  - Gil M

AU  - Gregory W

AU  - Cameron D

ED  - 

DO  - DOI: 10.1158/1538-7445.sabcs16-p6-17-01

PB  - American Association for Cancer Research (AACR)

VL  - 77

IS  - 4_Supplement

Y2  - 2024/12/26

ER  -